Predicted ten-year risk of cardiovascular disease among patients without prior heart disease or stroke using atherosclerotic cardiovascular disease risk calculator
Researcher Bulletin of Medical Sciences,
Vol. 27 No. 1 (2022),
20 November 2022
,
Page e11
Abstract
Objective: Recognition of probable risk factors for cardiovascular disease is crucial in non-CAD patients for preventive programming. The purpose was determination of 10-year cardiovascular disease (CVD) among patients without current cardiovascular disease.
Material & Methods: In this observational study that was performed as a diagnostic survey, 606 consecutive patients without current cardiovascular disease, referring to Modarres and Loghman Hospitals, Tehran, Iran in 2017 and 2018 were enrolled and ASCVD plus score determined the 10-year cardiovascular disease among them.
Results: The results in this study demonstrated that mean ASCVD plus score was 13.1 ± 14.9 points. Among cases 284 (40.9%), 67 (11.1%), 154 (25.4%), and 137 (22.6%) patients were in groups 1, 2, 3, and 4, respectively. The mean risk was higher in men, diabetics, smoker, users of anti-hypertensive, statins, and aspirin, older, with higher blood pressure, and also with higher total and LDL cholesterols.
Conclusion: Totally, according to the obtained results in current study, it may be concluded that 10-year risk of cardiovascular disease is relatively high among patients without current cardiovascular disease. This matter shows the importance of routine screening in such population.
- CVD; Risk; General population
How to Cite
References
2. Mao CT, Tsai ML, Wang CY, Wen MS, Hsieh IC, Hung MJ, et al. Outcomes and characteristics of patients undergoing percutaneous angioplasty followed by below-knee or above-knee amputation for peripheral artery disease. PloS one. 2014;9(10): e111130.
3. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007;50(1): 40-7.
4. Karmali KN, Lloyd-Jones DM. Global Risk Assessment to Guide Blood Pressure Management in Cardiovascular Disease Prevention. Hypertension. 2017;69(3): e2-e9.
5. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease overall findings and differences by age for 316099 white men. Archives of internal medicine. 1992;152(1): 56-64.
6. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18): 1837-47.
7. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The lancet. 2004;364(9438): 937-52.
8. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. The Lancet. 2010;376(9735): 112-23.
9. Barzin M, Mirmiran P, Afghan M, Azizi F. Distribution of 10-year risk for coronary heart disease and eligibility for therapeutic approaches among Tehranian adults. Public Health. 2011;125(6): 338-44.
10. Stone NJ, Robinson JG, Lichtenstein AH, Merz CNB, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation. 2014;129(25 suppl 2): S1-S45.
11. Motamed N, Mardanshahi A, Saravi BM, Siamian H, Maadi M, Zamani F. The 10-year Absolute Risk of Cardiovascular (CV) Events in Northern Iran: a Population Based Study. Mater Sociomed. 2015;27(3): 158-62.
12. Setayeshgar S, Whiting SJ, Vatanparast H. Prevalence of 10-year risk of cardiovascular diseases and associated risks in canadian adults: the contribution of cardiometabolic risk assessment introduction. Int J Hypertens. 2013;2013: 276564.
13. Motamed N, Rabiee B, Perumal D, Poustchi H, Miresmail SJ, Farahani B, et al. Comparison of cardiovascular risk assessment tools and their guidelines in evaluation of 10-year CVD risk and preventive recommendations: A population based study. Int J Cardiol. 2017;228: 52-7.
14. Celik M, Yuksel UC, Yildirim E, Gursoy E, Koklu M, Yasar S, et al. The relationship between blood pressure variability and Pooled Cohort Risk Assessment Equations 10-year cardiovascular risk score. Blood Press Monit. 2016;21(5): 282-7.
15. Ama Moor VJ, Nansseu JR, Nouaga ME, Noubiap JJ, Nguetsa GD, Tchanana G, et al. Assessment of the 10-year risk of cardiovascular events among a group of Sub-Saharan African post-menopausal women. Cardiol J. 2016;23(2): 123-31.
16. Ama Moor VJ, Nansseu JRN, Azingni DBT, Kaze FF. Assessment of the 10-year risk of cardiovascular disease among a group of patients on maintenance hemodialysis: A cross-sectional study from Cameroon. JRSM Cardiovasc Dis. 2017;6: 2048004017705273.
17. Ferket BS, Hunink MG, Khanji M, Agarwal I, Fleischmann KE, Petersen SE. Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease. Heart. 2017;103(7): 483-91.
- Abstract Viewed: 191 times